Debu Tripathy


Examining Racial and Ethnic Disparities in Cancer Care

February 19, 2021

The past year has spotlighted racial inequities not only in the U.S., but worldwide. It has also opened our eyes as to how a major health disruption — in this case, a pandemic — can aggravate the unacceptable status quo.

A Worthwhile Investment

October 30, 2015

Receiving a cancer diagnosis is a turning point, a moment at which patients need to start determining what seems like the right treatment path and exerting their best efforts to make it happen.

Debu Tripathy Discusses a Clinical Trial of Ibrance in Breast Cancer

June 11, 2015

Debu Tripathy, editor-in-chief of CURE and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses adding the targeted drug Ibrance to the hormonal drug Faslodex.